Pricing
  1. US-listed companies
  2. IDEXX LABORATORIES INC
  3. Financials
  4. Accounts receivable, net

IDEXX LABORATORIES INC (IDXX)

Market cap
$45.8B
P/E ratio
SummaryFinancials
Period EndAccounts receivable, net (Million USD)YoY (%)
Dec 31, 2024474+3.53%
Dec 31, 2023457+14.18%
Dec 31, 2022401+8.76%
Dec 31, 2021368+11.14%
Dec 31, 2020331+23.07%
Dec 31, 2019269+8.22%
Dec 31, 2018249+6.08%
Dec 31, 2017235+14.72%
Dec 31, 2016204+8.59%
Dec 31, 2015188+23.58%
Dec 31, 2014152-3.58%
Dec 31, 2013158+14.25%
Dec 31, 2012138-2.09%
Dec 31, 2011141+17.65%
Dec 31, 2010120

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat